Not Signed In -
Multiple Sclerosis |
Ms |
Multiple sclerosis (abbreviated MS, also known as disseminated sclerosis) is a chronic, inflammatory disease that affects the central nervous system (CNS). MS can cause a variety of symptoms, including changes in sensation, visual problems, muscle weakness, depression, difficulties with coordination and speech, and pain. Although many patients lead full and rewarding lives, MS can cause impaired mobility and disability in the more severe cases. Multiple sclerosis affects neurons, the cells ...
Wikipedia - [full article]
Multiple Sclerosis Clinical Trials
- BEYOND Study - Betaferon/Betaseron Efficacy Yielding Outcomes of a New Dose in Multiple Sclerosis (MS) Patients
ClinicalTrials.gov Identifier: NCT00099502 - Active, not recruiting
Multiple Sclerosis
- A Study to Evaluate Rituximab in Adults with Relapsing Remitting Multiple Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00097188 - Active, not recruiting
Multiple Sclerosis
- Safety of RG2077 in Patients With Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00076934 - Active, not recruiting
Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting
- Auditory Function in Patients With and Without Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00037947 - Recruiting
Multiple Sclerosis
- Rebif® New Formulation in Relapsing Forms of Multiple Sclerosis (RMS)
ClinicalTrials.gov Identifier: NCT00110396 - Active, not recruiting
Multiple Sclerosis
- Combination Therapy with Avonex and BiMonthly High Dose Intravenous Methotrexate in Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00037102 - Active, not recruiting
Multiple Sclerosis
- Safety Study of RTL1000 (Recombinant T Cell Receptor Ligand) in Subjects With Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00411723 - Recruiting
Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting
- EARLY IFNb-1a and Atorvastatin Combination Therapy of Isolated Clinical Syndrome Suggestive of Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00137176 - Recruiting
Multiple Sclerosis
- EARLY IFNB-1a and Simvastatin Combination Therapy in Clinically Isolated Syndrome Suggestive of Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00146068 - Recruiting
Multiple Sclerosis
- Evaluation of Efficiency of Ritalin in Multiple Sclerosis (MS) Patients
ClinicalTrials.gov Identifier: NCT00220493 - Recruiting
Relapsing Remitting Multiple Sclerosis; Multiple Sclerosis, Chronic Progressive
- A Study to Evaluate the Safety and Efficacy of Rituximab in Adults with Primary Progressive Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00087529 - Active, not recruiting
Multiple Sclerosis
- Improving Memory in Patients with Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00062972 - Recruiting
Multiple Sclerosis
- Magnetic Resonance Imaging (MRI) to Evaluate Activity of Multiple Sclerosis (MS)
ClinicalTrials.gov Identifier: NCT00001248 - Recruiting
Multiple Sclerosis
- Magnetic Resonance Imaging to Detect Brain Damage in Patients with Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00099307 - Recruiting
Multiple Sclerosis
- Immunotherapy with BHT-3009 Alone or Combined with Atorvastatin in Patients with Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00103974 - Active, not recruiting
Multiple Sclerosis
- POPART''MUS : Prevention of Post Partum Relapses with Progestin and Estradiol in Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00127075 - Recruiting
Multiple Sclerosis
- Atorvastatin Therapy in Patients With Clinically Isolated Syndrome (CIS) at Risk for Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00094172 - Recruiting
Multiple Sclerosis
- A Phase 2 study in Multiple Sclerosis patients to determine the safety of different doses of RO0506997 compared to placebo and their effects on Multiple Sclerosis lesions.
ClinicalTrials.gov Identifier: NCT00104143 - Not yet recruiting
Multiple Sclerosis
- Efficacy and Safety of Fingolimod in Patients With Relapsing-Remitting Multiple Sclerosis With Optional Extension Phase
ClinicalTrials.gov Identifier: NCT00340834 - Active, not recruiting
Multiple Sclerosis
- Safety and Efficacy Study of Doxycycline in Combination With Interferon-B-1a to Treat Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00246324 - Active, not recruiting
Multiple Sclerosis
- GER-009-06-AVX Early Therapy in Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00492570 - Active, not recruiting
Relapsing-Remitting Multiple Sclerosis
- Extension Study to Evaluate Safety, Tolerability and Effects on Efficacy Parameters of FTY720 in Patients With Relapsing Multiple Sclerosis.
ClinicalTrials.gov Identifier: NCT00235430 - Active, not recruiting
Multiple Sclerosis
- Prospective, Open-Label Tolerability and Safety Monitoring Study of Novantrone in a Selected Cohort of Multiple Sclerosis Patients
ClinicalTrials.gov Identifier: NCT00262314 - Active, not recruiting
Multiple Sclerosis
- Zenapax to Treat Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00001934 - Active, not recruiting
Multiple Sclerosis
- Efficacy and Safety of Fingolimod in Patients With Relapsing-Remitting Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00289978 - Active, not recruiting
Multiple Sclerosis
- Immunological Mechanisms of Hematopoietic Stem Cell Transplantation in Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00342134 - Active, not recruiting
Multiple Sclerosis
- Evaluation of the Efficacy of Cesamet™ for the Treatment of Pain in Patients With Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00381264 - Active, not recruiting
Multiple Sclerosis
- Phase III Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Immune Globulin for Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00004744 - Active, not recruiting
Multiple Sclerosis
- Safety and Effectiveness of Two Doses of ABT-874 as Compared to Placebo in Subjects with Multiple Sclerosis (MS)
ClinicalTrials.gov Identifier: NCT00086671 - Completed
Multiple Sclerosis; Multiple Sclerosis, Relapsing Remitting; Multiple Sclerosis, Secondary Progressive
- Long Term Study of Avonex Therapy Following a First Attack of Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00179478 - Active, not recruiting
Multiple Sclerosis; Optic Neuritis; Transverse Myelitis; Acute Brainstem/Cerebellar Syndrome
- Multimodal MRI in Multiple Sclerosis (MS): Reliability and Follow Up
ClinicalTrials.gov Identifier: NCT00289159 - Active, not recruiting
Multiple Sclerosis
- Restoration of Walking in Multiple Sclerosis Using Treadmill Training.
ClinicalTrials.gov Identifier: NCT00156676 - Recruiting
Multiple Sclerosis
- Stress Management for Patients with Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00147446 - Recruiting
Multiple Sclerosis
- Treatment of Multiple Sclerosis with Copaxone and Albuterol
ClinicalTrials.gov Identifier: NCT00039988 - Active, not recruiting
Autoimmune Diseases; Multiple Sclerosis
- Combination Therapy of Betaseron-Prograf in Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00298662 - Active, not recruiting
Multiple Sclerosis
- Follow-up Study of the BENEFIT Study (Betaferon® / Betaseron® in Newly Emerging Multiple Sclerosis for Initial Treatment)
ClinicalTrials.gov Identifier: NCT00185211 - Active, not recruiting
Multiple Sclerosis
- Safety of Avonex Treatment in Multiple Sclerosis Patients With Neutralizing Antibodies to Interferon Beta Therapy
ClinicalTrials.gov Identifier: NCT00493077 - Recruiting
Multiple Sclerosis
- Safety and Efficacy of Orally Administered Laquinimod for Treatment of Relapsing Remitting Multiple Sclerosis (RRMS)
ClinicalTrials.gov Identifier: NCT00509145 - Recruiting
Multiple Sclerosis
- The Effects of TYSABRI Treatment on Vaccination Response and Lymphocyte Subsets in Subjects With Relapsing Forms of Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00536120 - Recruiting
Multiple Sclerosis
- Stem Cell Therapy for Patients With Multiple Sclerosis Failing Interferon A Randomized Study
ClinicalTrials.gov Identifier: NCT00273364 - Recruiting
Multiple Sclerosis
- High-Dose Immunosuppression and Autologous Transplantation for Multiple Sclerosis (HALT MS) Study
ClinicalTrials.gov Identifier: NCT00288626 - Recruiting
Multiple Sclerosis
- Pilot Study of Teriflunomide as Adjunctive Therapy to Glatiramer Acetate in Subjects With Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00475865 - Recruiting
Multiple Sclerosis
- A Safety Study of Combination Treatment With Avonex and Placebo-Controlled Dosing of Topamax in Relapsing-Remitting Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00217295 - Recruiting
Multiple Sclerosis
- TCV -01-002: T-Cell Vaccination in the Treatment of Probable Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00228228 - Recruiting
Multiple Sclerosis
- Magnetic Resonance Imaging to Detect Brain Damage in Patients With Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00321568 - Recruiting
Multiple Sclerosis
- Efficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing-Remitting Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00355134 - Recruiting
Multiple Sclerosis
- Magnetic Resonance Imaging to Detect Brain Damage in Patients With Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00393588 - Recruiting
Multiple Sclerosis
- Pilot Study of Teriflunomide as Adjunctive Therapy to Interferon-β in Subjects With Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00489489 - Recruiting
Multiple Sclerosis
- A Study of C105 on Cognitive Dysfunction in Persons With Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00529581 - Recruiting
Cognition Disorders; Multiple Sclerosis
- Comparison of Alemtuzumab and Rebif Efficacy in Multiple Sclerosis, Study One
ClinicalTrials.gov Identifier: NCT00530348 - Recruiting
Multiple Sclerosis, Relapsing-Remitting
- Comparison of Alemtuzumab and Rebif Efficacy in Multiple Sclerosis, Study Two
ClinicalTrials.gov Identifier: NCT00548405 - Recruiting
Multiple Sclerosis, Relapsing-Remitting
- Safety Study of Natalizumab to Treat Multiple Sclerosis (MS)
ClinicalTrials.gov Identifier: NCT00559702 - Recruiting
Secondary Progressive Multiple Sclerosis
- Safety/Effectiveness of Adding Monthly Dexamethasone to Weekly Avonex for MS
ClinicalTrials.gov Identifier: NCT00232193 - Recruiting
Relapsing-Remitting Multiple Sclerosis,; Mono-Symptomatic Multiple Sclerosis
- Success of Titration, Analgesics, and B.E.T.A Nurse Support on Acceptance Rates in Early MS Treatment With Betaseron
ClinicalTrials.gov Identifier: NCT00461396 - Recruiting
Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting
- Trial of Memantine for Cognitive Impairment in Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00300716 - Recruiting
Multiple Sclerosis; Cognition Disorders
- Safety and Efficacy of Cellcept and Avonex as Combination Treatment in Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00324506 - Recruiting
Multiple Sclerosis
- Gait Evaluation in Multiple Sclerosis Patients Treated With Glatiramer Acetate
ClinicalTrials.gov Identifier: NCT00331747 - Recruiting
Multiple Sclerosis
- Efficacy and Safety of FTY720 in Patients With Relapsing Multiple Sclerosis (MS)
ClinicalTrials.gov Identifier: NCT00537082 - Recruiting
Multiple Sclerosis
- Firategrast (SB683699) Surface Area Study in Multiple Sclerosis Patients
ClinicalTrials.gov Identifier: NCT00548769 - Recruiting
Multiple Sclerosis
- A Study to Assess the Effects of MK-0812 on Disease Activity in Patients With Relapsing-Remitting Multiple Sclerosis as Measured by MRI.
ClinicalTrials.gov Identifier: NCT00239655 - Active, not recruiting
Relapsing-Remitting Multiple Sclerosis
- Clinical Trial Comparing Treatment of Relapsing-Remitting Multiple Sclerosis (RR-MS) With Two Doses of Glatiramer Acetate (GA).
ClinicalTrials.gov Identifier: NCT00337779 - Active, not recruiting
Relapsing Remitting Multiple Sclerosis
- Open Label Study to Evaluate Effect, Safety and Tolerability of Betaferon Standard Dose of 250 µg in Patients of Chinese Origin With Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00370071 - Recruiting
Multiple Sclerosis
- Zenapax (Daclizumab) to Treat Relapsing Remitting Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00071838 - Active, not recruiting
Multiple Sclerosis, Relapsing-Remitting
- Extension of Prior Study Evaluating Safety and Tolerability of Two Doses of Betaseron® to Treat Relapsing-Remitting Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00235989 - Active, not recruiting
Multiple Sclerosis, Relapsing-Remitting
- Phase II High-Dose Cyclophosphamide for Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00296205 - Recruiting
Multiple Sclerosis
- Brain Peripheral Benzodiazepine Receptors in Patients With Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00432900 - Recruiting
Multiple Sclerosis
- Modulation of Plasmacytoid Dendritic Cell Function in Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00468182 - Recruiting
Multiple Sclerosis
- IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00488839 - Recruiting
Multiple Sclerosis
- Donor Stem Cell Transplantation for the Treatment of Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00497952 - Recruiting
Multiple Sclerosis
- Phase IV, Rater-Blinded, Randomized Study, Comparing the Effects of 250 Mg of Betaseron With 20 Mg of Copaxone in Patients With the Relapsing-Remitting or Clinically Isolated Forms of Multiple Sclerosis Using 3 Tesla MRI With Triple-Dose Gadolinium
ClinicalTrials.gov Identifier: NCT00176592 - Active, not recruiting
Multiple Sclerosis
- Restoration of Walking in Multiple Sclerosis Using Treadmill Training
ClinicalTrials.gov Identifier: NCT00127426 - Not yet recruiting
Multiple Sclerosis
- Multiple Sclerosis Rehabilitation Study
ClinicalTrials.gov Identifier: NCT00202254 - Active, not recruiting
Multiple Sclerosis
- A Phase II Study Comparing Low- and High-Dose CAMPATH and High-Dose Rebif in Patients With Early, Active Relapsing-Remitting Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00050778 - Active, not recruiting
Multiple Sclerosis, Relapsing-Remitting
- Registry to Evaluate Novantrone (R) Effects in Worsening Multiple Sclerosis (RENEW)
ClinicalTrials.gov Identifier: NCT00016614 - No longer recruiting
Multiple Sclerosis
- Efficacy of Anti-Tubercular Vaccination in Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00202410 - Recruiting
Multiple Sclerosis
- Infections and Autoimmunity: Autobodies Screening in Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00230204 - Recruiting
Multiple Sclerosis
- Multiple Sclerosis and Heavy Progressive Resistance Training
ClinicalTrials.gov Identifier: NCT00381576 - Recruiting
Multiple Sclerosis
- Correlation Between Cognitive Functions and MRI in Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00423111 - Recruiting
Multiple Sclerosis
- Aspirin for Treatment of Multiple Sclerosis-Related Fatigue
ClinicalTrials.gov Identifier: NCT00467584 - Recruiting
Multiple Sclerosis
- Neuroprotection With Riluzole Patients With Early Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00501943 - Recruiting
Multiple Sclerosis
- Phase III Study of Teriflunomide in Reducing the Frequency of Relapses and Accumulation of Disability in Patients with Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00134563 - Recruiting
Multiple Sclerosis with relapses
- Assessment Study of Steroid Effect in Relapsing Multiple Sclerosis Subjects Treated With Glatiramer Acetate
ClinicalTrials.gov Identifier: NCT00203047 - Recruiting
Relapsing Remitting Multiple Sclerosis
- Measuring the Balance Improvement on Multiple Sclerosis Patients After a Short Training Period With an APOS (All Phase Of Step Cycle) Kit
ClinicalTrials.gov Identifier: NCT00338637 - Recruiting
Multiple Sclerosis; Balance; Cerebelar Impairment
- The Effect of Sildenafil Citrate (Viagra® (Registered Trademark)) on Brain Blood Flow in Multiple Sclerosis Patients
ClinicalTrials.gov Identifier: NCT00094068 - Completed
Multiple Sclerosis
- MR Perfusion Imaging and Hypercapnia (Increased Carbon Dioxide) to Study New Blood Vessel Formation in Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00064909 - Completed
Multiple Sclerosis
- Antibiotic treatment trial directed against Chlamydia pneumonia in multiple sclerosis
ClinicalTrials.gov Identifier: NCT00043264 - Completed
Multiple Sclerosis
- Safety, Tolerability, and Effectiveness of CGP77116 in Patients with Multiple Sclerosis (MS)
ClinicalTrials.gov Identifier: NCT00001781 - Completed
Multiple Sclerosis
- Efficacy of Cyclophosphamide Versus Methylprednisolone in Patients With Secondary Progressive Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00241254 - Recruiting
Multiple Sclerosis, Chronic Progressive
- Study of Rebif® Compared With no Treatment in the Therapy of Relapsing Multiple Sclerosis After Mitoxantrone
ClinicalTrials.gov Identifier: NCT00283140 - Recruiting
Relapsing Remitting Multiple Sclerosis
- Comparison of Bone Effects With Copaxone and Interferon in Multiple Sclerosis: A Pilot Study
ClinicalTrials.gov Identifier: NCT00490906 - Recruiting
Multiple Sclerosis; Bone Density
- Simvastatin as an Add-on Treatment to Interferon-Beta-1a for the Treatment of Relapsing-Remitting Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00492765 - Recruiting
Multiple Sclerosis
- Efficacy of 3,4-DAP in Fatigue Associated With Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00190268 - Recruiting
Multiple Sclerosis
- T-Cell Vaccination in Multiple Sclerosis (MS)
ClinicalTrials.gov Identifier: NCT00220428 - Recruiting
Multiple Sclerosis
- Visual Impairment, Oscillopsia and Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00498199 - Recruiting
Multiple Sclerosis
- High Dose Chemo/Radiotherapy and Hematopoietic Stem Cell Transplant for Patients with Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00040482 - Completed
Multiple Sclerosis
- Optic Neuritis Treatment Trial (ONTT)
ClinicalTrials.gov Identifier: NCT00000146 - Active, not recruiting
Multiple Sclerosis; Optic Neuritis
- AVONEX® Combination Trial - "ACT"
ClinicalTrials.gov Identifier: NCT00112034 - Active, not recruiting
Multiple Sclerosis, Relapsing-Remitting
- Fish Oil for the Treatment of Depression in Patients with Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00122954 - Recruiting
Multiple Sclerosis; Depression
- BHT-3009 Immunotherapy in Relapsing Remitting Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00382629 - Active, not recruiting
Relapsing Remitting Multiple Sclerosis
- Efficacy and Safety Evaluation of Nabilone as Adjunctive Therapy to Gabapentin for the Management of Neuropathic Pain in Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00480181 - Recruiting
Neuropathic Pain; Multiple Sclerosis
Resources
- A Pacemaker for the Brain (Cleveland Clinic)
- ADA and People with Multiple Sclerosis (National Multiple Sclerosis Society)
email this page
print this page
bookmark this page
feedback on this page
